New Bill Just Dropped!

The American Medical Association, as well as MSD, have been sounding the alarms that physicians are facing yet another in a series of looming Medicare payment cuts, this time to the tune of 3.37% starting in 2024. With all the Congressional gridlock in Washington, DC the outcome looked bleak – that is until a bi-partisan group of legislators led by Rep. Greg Murphy, MD (R-NC) introduced H.R. 6683 the "Preserving Seniors' Access to Physicians Act." Legislation, that if enacted, would completely eliminate the scheduled 3.37% physician payment cut. Contact the Delaware Congressional Delegation and urge them to fix the flawed Medicare physician payment system by supporting H.R. 6683. If Congress includes this critical legislation as part of the 2024 appropriations package, a potentially disastrous situation for Medicare patients and their physicians could be avoided, but time is running out! Congress only has until January 19th to act, avoid a government shutdown and fund programs for the coming year. Take action now! The looming 3.37% reduction comes after three years of consecutive cuts to Medicare services. If Congress does not act now, Medicare payments will have been cut by almost 10% in four years, which is simply unsustainable for our nation's physicians. In fact, due to these past cuts and the potential for additional Medicare cuts, physician practices and integrated systems of care have and will continue to eliminate services. This includes implementing hiring freezes, delaying system improvements and the transition to new value-based care systems. The effects of these cuts will be exacerbated in rural and underserved areas, which continue to face significant health care access challenges. Medicare physicians and other providers do not receive inflationary updates in the Medicare program, which is partially why eliminating these potential cuts is so crucial. Inaction is not an option - Take action now! and urge them to support including H.R. 6683 in the upcoming 2024 appropriations package! Everyone agrees the Medicare physician payment system is broken, and it's time for Congress to do something about it before it's too late. 

AMA Shares Two Recent Policy Research Perspectives

The American Medical Association is sharing two recent Policy Research Perspectives out of its Health Policy Group. Each report is based on data from the AMA’s Physician Practice Benchmark Survey. The first, Telehealth in 2022: Availability Remains Strong but Accounts for a Small Share of Patient Visits for Most Physicians, documents the growth of telehealth availability in physician practices over the 2018 to 2022 period. It also presents specialty-specific estimates of the average number of remote patient visits provided per week. The second, Payment and Delivery in 2022: Continued Growth in Accountable Care Organization While Alternative Payment Methods Stagnate, provides a detailed look at the extent to which physicians are in practices that participate in medical homes and accountable care organizations (ACOs) as well as involvement in alternative payment methods (APMs).

There Is Still Time to Give for 2023

The 1789 Club recognizes the philanthropic investment by physicians in the future of medicine in the state of Delaware, and the part the Medical Society of Delaware will play in shaping that future. Donors providing a gift of at least $1,789 are part of an exclusive cohort on the 1789 Club donor wall and receive a special 1789 Club lapel pin that is a reproduction of our Society’s original Seal. Join today by giving to the MSD Mission Appeal and help lead the way to a healthy Delaware!

Thank you to all who donated to the 2023 Mission Appeal. Your support allows us to grow and sustain the Delaware Foundation for Medical Services (DFMS) and Delaware Medical Education Foundation (DMEF). It is never too late to give. Please consider the foundations in your 2024 charitable giving.

Insight into Your Perceptions of DCPAP Services

The Delaware Child Psychiatry Access Program (DCPAP) is a statewide program that provides pediatric primary care professionals with free child psychiatry consultation and behavioral health training. DCPAP is embarking on an important initiative to better understand the perspectives of Delaware physicians and other health care professionals who may be seeking support for their pediatric patients with behavioral health disorders. In partnership with Aloysius Butler & Clark (AB&C), DCPAP is hoping to conduct 30-minute phone interviews with Delaware health care professionals to gain insight into your perceptions of DCPAP services. AB&C is the same organization that assisted MSD in its recent strategic planning initiative. As a thank-you, participating health care professionals will receive a $30 Amazon gift card after completing the interview. AB&C and DCPAP want to assure you that your feedback and personal information will remain anonymous during this interview process. If you are interested in participating, please email David Brond (dbrond@abccreative.com) with your availability and to get the interview scheduled.

DPH Launches New Campaign on Preventing Severe Outcomes

The Delaware Division of Public Health (DPH) takes the safety and well-being of all Delawareans seriously. With COVID-19, flu and RSV all prevalent this time of year, DPH is actively educating residents about how to mitigate exposure and transmission of these respiratory viruses. Keeping in the spirit of the holiday season, DPH has taken a lighthearted approach and launched a fun, new, holiday-themed campaign reminding all Delawareans of four simple guidelines that can help them stay safe from respiratory viruses this winter: Get vaccinated for COVID-19, flu and RSV, if eligible; stay home if you are sick; if you have symptoms or were exposed to someone with a respiratory illness, get tested and seek treatment if you test positive; and if cases rise or you are immunocompromised, consider wearing a mask. DPH also compiled a list of tips and resources to further ensure viruses take a backseat to gatherings and celebrations.

CDC Issues Health Advisory: Increased Respiratory Disease Activity

The Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) Health Advisory to alert health care professionals of low vaccination rates against influenza, COVID-19, and RSV (respiratory syncytial virus). Low vaccination rates, coupled with ongoing increases in national and international respiratory disease activity caused by multiple pathogens, including influenza viruses, SARS-CoV-2 (the virus that causes COVID-19), and RSV, could lead to more severe disease and increased health care capacity strain in the coming weeks. In addition, a recent increase in cases of multisystem inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection in the United States has been reported. Health care professionals should administer influenza, COVID-19, and RSV immunizations now to patients, if recommended. Health care professionals should recommend antiviral medications for influenza and COVID-19 for all eligible patients, especially patients at high-risk of progression to severe disease such as older adults and people with certain underlying medical conditions. Health care professionals should also counsel patients about testing and other preventive measures, including covering coughs/sneezes, staying at home when sick, improving ventilation at home or work, and washing hands to protect themselves and others against respiratory diseases.

Program Offers Testing, Telehealth, and Treatment for COVID and Flu

The federal government has expanded the Home Test to Treat program, an entirely virtual community health program that offers free COVID-19 health services: at-home rapid tests, telehealth sessions and at-home treatments, to eligible participants nationwide. Home Test to Treat, which is a collaboration among the National Institutes of Health, the Administration for Strategic Preparedness and Response, and the Centers for Disease Control and Prevention, launched as a pilot in select locations earlier this year. With its expansion, the Home Test to Treat program will now offer free testing, telehealth and treatment for both COVID-19 and for influenza (flu) A and B. It is the first public health program that includes home testing technology at such a scale for both COVID-19 and flu. The program initially will provide the LUCIRA® by Pfizer COVID-19 & Flu Home Test, the first U.S. Food and Drug Administration-authorized test that can detect both viruses in a single test at home. For those indicated, treatment must begin within a limited window from onset of symptoms, underscoring the importance of continuity of care, from diagnosis to treatment. In addition, providing these services virtually, while individuals remain at home, is intended to expedite the time to treatment and the convenience of accessing services virtually from home. Any adult (18 years and older) with a current positive test for COVID-19 or flu can enroll to receive free telehealth care and, if prescribed, medication delivered to their home. Adults who do not have COVID-19 or flu may enroll and receive free tests if they are uninsured or are enrolled in Medicare, Medicaid, Veterans Affairs health care system, or the Indian Health Services. If recipients test positive at a future time, they can receive free telehealth care and, if prescribed, treatment.

JN.1 Is a Closely Related Offshoot of BA.2.86 Variant

JN.1, a variant of the virus that causes COVID-19, is a closely related offshoot of the variant BA.2.86 that the Centers for Disease Control and Prevention (CDC) has been tracking since August. JN.1 is currently projected to comprise 15-29% of circulating variants and continues to grow quickly compared with other variants. Its continued growth suggests that it is either more transmissible or better at evading our immune systems. At this time, there is no evidence that JN.1 presents an increased risk to public health relative to other currently circulating variants, and CDC is closely monitoring COVID-19 activity and JN.1 spread. The increase of this variant does not alter CDC’s COVID-19 recommendations, meaning that vaccines, tests, and treatments continue to work well against JN.1.

MammogramNow^TM Screening Service

RadNet, Inc. a national outpatient diagnostic imaging services provider, announced MammogramNow, an innovative screening mammography service that debuted at the Walmart Supercenter in Milford, Delaware, on December 8th. This initiative aims to enhance breast health awareness and accessibility into the Walmart Supercenter environment, providing women with convenient access to crucial breast cancer screening services. Harnessing state-of-the-art hardware and software technology, powered by DeepHealth Artificial Intelligence (AI), this program pursues an improved level of screening performance and promotes earlier detection. MammogramNow offers women access to RadNet’s Enhanced Breast Cancer Detection service, incorporating AI to optimize disease detection seamlessly during their visits, without extending their appointment time.

CMS Guidance Outlines How States Can Connect Individuals Needing Care

The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), took another critical step to improve access to home- and community-based services (HCBS) by reminding states of tools to better connect direct support workers to individuals receiving Medicaid-covered HCBS, such as individuals with disabilities and older adults. The agency’s new guidance focuses on building and maintaining worker registries — worker management platforms that make qualified health workers easier to find — so more individuals receiving Medicaid-covered services can receive care in a setting of their choice. The guidance also notes significant federal funding available to help states build these registries thanks to the American Rescue Plan (ARP). Even before the COVID-19 public health emergency, shortages of direct support workers meant that many people were left with limited care choices, which sometimes lead individuals to receive care unnecessarily in institutional settings like nursing homes. One way to address this challenge is by leveraging worker registries to help Medicaid recipients answer two critical questions: Who is qualified to provide HCBS in my state, and how can I find them? In addition to highlighting the value and mechanics of building worker registries, CMS’ guidance reiterates that states can access enhanced federal funding, including through the ARP, to develop and publicly post these lists of workers. Doing so can help with recruiting and retaining workers already in short supply. By better facilitating access to a robust pool of direct support workers, states can help more people find qualified professionals for their needs. This can improve quality of care and allow more individuals to remain in the community while strengthening the direct care workforce in states. CMS also released data on how enhanced funding for HCBS provided through the ARP has been invested to strengthen access to HCBS across the country. This guidance marks another step towards supporting access to quality HCBS so older adults and individuals with disabilities can live safely and independently in their homes and communities.

List of 48 Prescription Drugs That Coinsurances May Be Lower

On December 14, the Centers for Medicare & Medicaid Services (CMS) released revised guidance detailing key requirements and procedures for calculating rebates and invoicing manufacturers that owe rebates to Medicare under the Medicare Prescription Drug Inflation Rebate Program for certain drugs covered under Medicare Part B and Part D. CMS also released the list of 48 prescription drugs for which Part B beneficiary coinsurances may be lower between January 1, 2024 – March 31, 2024. More information about these 48 Part B drugs and biological products can be found in the quarterly Average Sales Price (ASP) public files, available here (PDF). A fact sheet is available here (PDF). This coinsurance adjustment applies to certain drugs and biologicals paid under Medicare Part B. The Part B drugs impacted by this coinsurance adjustment may change quarterly.

Nominations Being Accepted to Serve as Voting or Non-Voting Member

The US Food and Drug Administration (FDA) announced the new Genetic Metabolic Diseases Advisory Committee (GeMDAC) to help the agency explore the complex issues related to genetic metabolic disease drug development. Genetic metabolic diseases are rare genetic conditions that interfere with a person’s metabolism, the body’s ability to convert food into energy and remove waste and unhealthy substances. There are hundreds of genetic metabolic diseases, and many have few or no treatment options. The GeMDAC will advise FDA on the safety and effectiveness of human drug and biological products under investigation or submitted for marketing approval for use in the treatment of genetic metabolic diseases. The committee will consist of nine voting members with technical and scientific expertise from diverse disciplines and backgrounds. Committee members will be invited to serve for overlapping terms of up to four years. The number of temporary voting members selected for a particular meeting will depend on the meeting topic. In addition to the voting members, the committee may include one non-voting industry representative.

Those interested in serving or nominating a representative to serve as a voting or non-voting member of the GeMDAC, may either submit nominations electronically by accessing the FDA Advisory Committee Membership Nomination Portal or by mail. Nominations should be submitted no later than February 11, 2024. Learn more about the GeMDAC.

FDA Approves First Cell-Based Therapies to Treat Patients 12 and Older

The U.S. Food and Drug Administration (FDA) approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signaling an innovative advancement in the field of gene therapy. Both products are made from the patients’ own blood stem cells, which are modified, and are given back as a one-time, single-dose infusion as part of a hematopoietic (blood) stem cell transplant. Prior to treatment, a patients’ own stem cells are collected, and then the patient must undergo myeloablative conditioning (high-dose chemotherapy), a process that removes cells from the bone marrow so they can be replaced with the modified cells in Casgevy and Lyfgenia. Patients who received Casgevy or Lyfgenia will be followed in a long-term study to evaluate each product’s safety and effectiveness. 

USPSTF Draft Recommendation Statement on Interventions for High BMI

The U.S. Preventive Services Task Force (USPSTF) seeks comments on a draft recommendation statement and draft evidence review on interventions for high body mass index (BMI) in children and adolescents. The Task Force recommends that clinicians offer or refer children and adolescents with high BMI to behavioral interventions to help manage their weight and stay healthy. In 2017, the USPSTF had recommended that screening for obesity start at age 6; however, research since then has shown the effectiveness of intensive behavioral interventions for achieving a healthy weight and improving the quality of life for children and adolescents. The Task Force's recommendations do not include weight loss medications or surgery. The draft recommendation statement and draft evidence review are available for review and public comment from December 12, 2023, to January 16, 2024 here. Note the public comment period has been expanded from the standard four weeks to five weeks to account for the holidays.

Trusted Exchange Framework and Common Agreement Now Operational

The U.S. Department of Health and Human Services (HHS), through the Office of the National Coordinator for Health Information Technology (ONC), announced on Tuesday this week that nationwide health data exchange governed by the Trusted Exchange Framework and Common Agreement^SM (TEFCA) is now operational. ONC has led a multi-year, public-private process alongside its Recognized Coordinating Entity®, The Sequoia Project, Inc., to implement TEFCA, which was envisioned by the 21st Century Cures Act. As a result, patients will have increased access to their records, and health care professionals and plans can improve their secure exchange of electronic health information. The following organizations were officially designated Qualified Health Information Networks™ (QHINs™) after completing the rigorous TEFCA onboarding process:

• eHealth Exchange
• Epic Nexus
• Health Gorilla
• KONZA
• MedAllies

These designated QHINs can immediately begin supporting the exchange of data under the Common Agreement’s policies and technical requirements. QHINs are the pillars of TEFCA network-to-network exchange, providing shared services and governance to securely route queries, responses, and messages across networks for eligible participants including patients, providers, hospitals, health systems, payers, and public health agencies. Health information network Surescripts and EHR vendor eClinicalWorks have recently applied to become QHINs.

The Joint Commission Updates Definition to Extend Time Frame, Services

The Joint Commission revised its definition of suicide in the Sentinel Event Policy, effective Jan. 1, 2024. The original definition, developed more than 10 years ago, focused on inpatient and “staffed around-the-clock” care settings or suicides within 72 hours of discharge. Data and evidence-based literature support extending the time frame and services in which a patient receives care when considering suicide as a sentinel event. The following is the revised definition of suicide in the Sentinel Event Policy: Death caused by self-inflicted injurious behavior if any of the following apply:

• While in a health care setting
• Within 7 days of discharge from inpatient services
• Within 7 days of discharge from emergency department (ED)
• While receiving or within 7 days of discharge from the following behavioral health care services:
• Day Treatment/Partial Hospitalization Program (PHP)/Intensive Outpatient Program (IOP)
• Residential
• Group Home
• Transitional Supportive Living

Refer Your High Risk Patients to Help Them Make Lifestyle Changes

If you have patients at risk for Type 2 Diabetes, they can make small, measurable changes that can reduce their risk and help them live a happier, healthier life. Lifestyle changes such as weight control, physical activity and healthy eating can help many people with prediabetes. They also may be eligible to participate in the YMCA's Diabetes Prevention Program with no out of pocket cost.

The program features:

• A year-long, evidence-based program designed to reduce your risk for diabetes through lifestyle change
• Offered at no cost to participants through participating insurance providers, including Medicare and Medicaid; the YMCA offers grant money to eligible participants to cover the cost of the program
• A four-month family membership to the YMCA of Delaware is included for active participants
• Each cohort is led by a trained lifestyle coach
• Goals – lose 7% of their starting body weight and increase physical exercise to 150 minutes of cardiovascular activity.

Patients who qualify based on a risk assessment score reflecting a high risk for developing prediabetes or type 2 diabetes can be eligible. To refer patients to the YMCA's Diabetes Prevention Program or other YMCA of Delaware Healthy Living Programs, please complete the Healthy Living Program Referral form with the patient's information, select the program(s) to which you are referring the patient, complete your information and submit. Other YMCA of Delaware Healthy Living Programs include:

• LiveSTRONG at the YMCA
• LEAN - Lifelong Essential for Activity & Nutrition
• Adaptive Fitness (Adults with disabilities who would like more information about Adaptive Fitness should contact the Health Living Department at healthyliving@ymcade.org or 302-572-9622.)

Application Deadline Extended to January 31st

The Physicians Foundation has extended its call for nominations for the Leadership Award Program! New or early-career physicians are now encouraged to apply by January 31, 2024. The Physicians Foundation’s Leadership Awards Program recognizes physicians for extraordinary actions in their practice or community. Award recipients will receive a $10,000 scholarship to elevate their efforts to address drivers of health (DOH) or advance innovative solutions to make their communities or practices a healthier place for patients and physicians.

Requirements include:

• Open to physicians who are new or early-career (practicing less than 15 years).
• Demonstrate physician leadership in relevant award category.
• Be nominated by a sponsor (mentor, colleague or peer) in coordination with the nominee. Sponsors should provide a short statement of recommendation.
• Submit a video component, current resume/CV and a statement that briefly describes how the scholarship will allow them to continue making positive, constructive contributions to the medical profession.

Confidential, Voluntary Questionnaire Developed to Capture Information

We continue to move the needle. We are now at 18% of our membership providing this information. The MSD Committee on Diversity, Equity, and Inclusion is working to support a diverse physician workforce and inclusive organizational culture. Previously, MSD did not collect racial, ethnic, and gender information about our members. As a starting point toward understanding and improving our membership diversity, your help is greatly appreciated in submitting this information. A brief, four-answer questionnaire has been developed and will take less than a minute to complete. Your information will remain confidential, however, it will be used in aggregate to assess the diversity of our membership, how that correlates with the diversity of our leadership and to understanding the diversity of the physician workforce in Delaware. Access the questionnaire.

"Kind to Kids" - Children, Teens in Foster Care Affected by Trauma

The Medical Society of Delaware (MSD) has selected Kind to Kids as our winter season charity fundraising beneficiary. Our goal is to raise $1,200 to help children and teens in foster care who are victims of child abuse and neglect. Your donation will provide direct support for a child in foster care. Kind to Kids is a foundation that helps meet the needs of children and teens in foster care who are deeply affected by the trauma in their lives. 100% of every dollar donated online will go directly to help a foster child during these difficult times. Please donate now and help us make a difference in the lives of these deserving kids. You can donate online at https://www.classy.org/fundraiser/5051939. Thank you for your support! 

No Newsletter the Week of December 25th

The MSD eNews and Views weekly newsletter will take a year-end break following the December 21st issue. The newsletter will resume with the January 4, 2024 issue. However, any high priority communications will be sent to the membership during the break.

Make the Case for Wellness Initiatives

Help your organization’s leadership understand the importance of supporting well-being initiatives. Literature shows us improving professional fulfillment and reducing burnout will help an organization reach its goals, whether it be access to care, patient satisfaction, or improved teamwork. Not only is physician burnout costly, organizations have a moral and ethical responsibility to protect their team members. 

LEARN MORE:

Toolkit:

• Establishing a Chief Wellness Officer Position
• Cultivating Leadership

Podcast:

• Practical Strategies for the Wellness-Centered Leader

Playbook:

• Wellness-Centered Leadership

AMA STEPS Forward^® offers a collection of engaging and interactive educational content designed to help put the joy back into medicine.

Don't Miss Filing: January 2nd Deadline

As the MIPS 2023 performance year winds down, there may be a reason for you to skip filing this year. If your practice has experienced Hardship or Extreme & Uncontrollable Circumstances, you may be eligible to exemptions. Find out all the details in Chirpy Bird's latest blog post.

Eligible Reasons to File an Exemption:

• Hardship
• Decertified EHR technology
• Insufficient Internet connectivity
• Lack control over the availability of CEHRT
• Extreme and Uncontrollable Circumstances
• Natural Disasters
• Public Health Emergencies
• Financial Distress
• Clinician/Staff Issues
• EHR Challenges
• Extreme Circumstances

Due to Potential for Lack of Sterility Assurance

In direct response to the Nurse Assist, LLC voluntary product recall (which included products supplied to Cardinal Health used in Covidien and Cardinal Health™ brand kits and trays), Cardinal Health issued a medical device recall on December 5, 2023, for its Covidien and Cardinal Health™ brand urology and operating room-specific kits and trays that contain 0.9% sodium chloride irrigation USP and sterile water for irrigation USP supplied by Nurse Assist. Under the Nurse Assist voluntary recall, this product is being recalled due to the potential for a lack of sterility assurance which could result in non-sterile product. In populations most at risk, such as patients who are immunocompromised, there is a possibility that the use of the affected product could potentially result in severe or life-threatening adverse events. There have been no reports of patient harm. Read more regarding which brand codes and lot numbers are affected that Cardinal Health has identified.

Due to Leaking Sachets

Cipla Limited announced that its wholly-owned subsidiary, InvaGen Pharmaceuticals Inc. is voluntarily recalling one lot of Vigabatrin for Oral Solution, USP 500mg, to the consumer level. Vigabatrin for Oral Solution, USP 500 mg has been found to have seal integrity issues allowing for powder leakage from the pouch. An improper seal in the pouch may lead to the leakage of powder blend outside the pouch, resulting in a lower content of medicine inside the pouch compared to the label claim and result in potential underdosing. The population at risk is primarily infants and young children. In those patients, there is a reasonable probability that inaccurate dosing might result in a serious adverse effect such as intoxication or breakthrough seizures requiring medical intervention. For a small minority of patients, who might have severe or repeated breakthrough seizures, a drop in their phenytoin blood levels could result in life-threatening seizures requiring immediate emergency room treatment. Cipla has not received any reports of adverse events related to this recall. The product is used for the treatment of Refractory Complex Partial Seizures as adjunctive therapy in patients 2 years of age and older who have responded adequately to several alternative treatments. Vigabatrin for oral solution is not indicated as a first-line agent. The medication is packaged in foil pouches, each containing 500mg of Vigabatrin, and there are 50 foil sealed pouches in a shelf pack. The affected lot is NB301030, with an expiration date of 03/2025. The Vigabatrin for Oral Solution, USP 500mg product was distributed nationwide to partnered distributors and consignees.

Bayhealth

Beebe Healthcare

ChristianaCare

Danielle Sanders, MD - ChristianaCare Pediatric Associates

MSD members are afforded a seven-day review period from the date of this publication to comment regarding applicants for membership. Please contact Michelle Seymour at (302) 224-4905 or Michelle.Seymour@medsocdel.org with any comments on the current pending member(s) listed above or if you know of someone interested in joining MSD. You could be eligible for a membership referral dues discount!

The Latin phrase Rerum Cognoscere translates to learn, examine, or become aware of facts or things. In this section, we highlight measurable items of interest in health care from MSD, Delaware, the US, and the world.

• Updates to Clinical Testing Guidance Algorithms - CDC has updated several testing guidance pages for patients with acute respiratory illness (1) not being hospitalized, (2) being hospitalized, and (3) hospitalized and non-hospitalized patients when SARS-CoV-2 and influenza viruses are co-circulating. Clinicians can use these updated resources to inform clinical decision making. (12/8/2023)
• Ellume tests available for those who are blind or have low vision (free at-home COVID-19 tests) https://acl.gov/accessibletests
• Find COVID-19 Vaccines: https://www.vaccines.gov/
• No Cost COVID-19 Testing Locator can help people find current community and pharmacy partners participating in the Increasing Community Access to Testing (ICATT) program.
• FDA At-Home OTC COVID-19 Diagnostic Tests provides a list of all FDA-authorized at-home over-the-counter (OTC) COVID-19 diagnostic tests
• Federal website for information on navigating COVID: COVID.gov
• CDC Isolation and Precautions for People with COVID-19
• COVID-19 Therapeutics Locator
• CDC COVID Data Tracker
• CDC will report regional-level test positivity data from the National Respiratory and Enteric Virus Surveillance System (NREVSS)
• COVID-19 by County Community Level Check (# hospital admissions and beds used and total number of new cases)
• (Delaware) General Questions: call 211 or email DPHCall@delaware.gov or Vaccine@delaware.gov for vaccine-specific questions.
• Latest information on Delaware's response (testing, treatment, vaccination): de.gov/coronavirus (Updated 2/2023)